United States Últimas notícias

Douglas Dynamics (NYSE:PLOW) announced its financial results for the second quarter of 2026, reporting record net sales of $214.6 million.

TG Therapeutics (NASDAQ:TGTX) reported Q2 global revenue of $240.3 million as U.S. BRIUMVI sales increased 64% to $227.7 million.

AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).

Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.

Ocular Therapeutix (NASDAQ:OCUL) reported Q2 revenue of $13.5 million and plans a Q4 AXPAXLI filing after FDA alignment.

IBM Vice Chairman Gary Cohn says, "the market became addicted to knowing what the Fed was going to do" as he discusses market reaction to Federal Reserve Chairman Kevin Warsh's handling of the US central bank. Cohn also discusses Japan and the US Treasury Department working together to shore up the yen and the instabilities being dealt with by markets. He speaks on "Bloomberg Surveillance."

Krystal Biotech (NASDAQ:KRYS) reported Q2 VYJUVEK revenue of $119.2 million, up 24%, and net income of $54.8 million.

Hess Midstream (NYSE:HESM) reported Q2 revenue of $399 million, net income of $173.7 million and adjusted free cash flow of $231.6 million.

IBM Vice Chairman Gary Cohn says, "the market became addicted to knowing what the Fed was going to do" as he discusses market reaction to Federal Reserve Chairman Kevin Warsh's handling of the US central bank. He speaks on "Bloomberg Surveillance."

Compugen (NASDAQ:CGEN) reported Q2 revenue of $2.6 million and said its $125.3 million cash position could fund operations into 2029.

Tyson Foods (NYSE:TSN) announced its financial results for the fiscal third quarter of 2026, reporting flat sales of $13.87 billion.

Lindblad Expeditions Holdings (NASDAQ:LIND) reported Q2 tour revenue of $199.2 million, up 19% year over year.